Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2007
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291617 Arylamidine derivative or salt thereof
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291607 Administering to the animal an effective amount of one or more maltsoyl-isomaltooligosaccharides having a degree of polymerization less than or equal to 7, such that number of beneficial intestinal bacteria increase substantially or that the number of pathogenic bacteria decrease
11/06/2007US7291588 Immunogenic detoxified mutant E. coli LT-A toxin
11/06/2007US7291343 Therapy for antibiotic resistance; immunotherapy
11/06/2007US7291337 Stable envelope protein; human t-cell leukemia, lymphoma viruses
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2363713C Lantibiotic
11/06/2007CA2271388C Liposomes encapsulating polynucleotides operatively coding for immunogenic polypeptides
11/06/2007CA2202058C Cyclic hexapeptides having antibiotic activity
11/01/2007WO2007123906A2 Recombinant antigens for diagnosis and prevention of murine typhus
11/01/2007WO2007123868A2 Organic thiophosphate antiretroviral agents
11/01/2007WO2007123236A1 Composition containing microorganism cell which can prevent development of hansen's disease
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123044A1 Licorice polyphenol preparation
11/01/2007WO2007122686A1 Benzimidazole compounds
11/01/2007WO2007122258A1 Tryclic nitrogen containing compounds and their use as antibacterials
11/01/2007WO2007121933A1 Crystalline modification of cefuroximaxetil
11/01/2007WO2007121893A1 Method for treating hpv infected patients
11/01/2007WO2007121491A1 Hcv vaccinations
11/01/2007WO2007090123A3 Mgra is a redox regulator of antibiotic sensitivity and virulence
11/01/2007WO2007089907A3 Cationic steroid antimicrobial compositions and methods of use
11/01/2007WO2007088438A3 Benzisoxazole oxazolidinones as antibacterial agents
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007022385A3 Use of cxcr4 binding molecules for the treatment of whim syndrome
11/01/2007WO2007015105A3 Nanoparticles comprising antibacterial ligands
11/01/2007WO2006103399A8 Hiv integrase inhibitors
11/01/2007WO2006062434A8 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations
11/01/2007WO2004032622A8 Production of peptides in plants as viral coat protein fusions
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
11/01/2007US20070254934 Antiviral drugs for treatment of arenavirus infection
11/01/2007US20070254924 Salts of benzimidazole compound and use thereof
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254872 Antibacterial Agents
11/01/2007US20070254871 Compounds for the Treatment of Inflammation of the Central Nervous System
11/01/2007US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007US20070254836 Glycopegylated Granulocyte Colony Stimulating Factor
11/01/2007US20070254329 Mammalian Genes Involved in Viral Infection and Tumor Suppression
11/01/2007US20070254044 Antimicrobial Amorphous Compositions
11/01/2007US20070254028 Granules Comprising a Nsaid and a Sugar Alcohol Made by Melt Extrusion
11/01/2007US20070254023 Perorally Administrable Antimicrobial Composition
11/01/2007US20070254009 Antibiotic/bone morphogenic protein formulation and method of treatment
11/01/2007US20070253980 New pharmaceutical composition from natural materials for regulating immunity, its preparation method and use
11/01/2007US20070253972 For expressing foreign genetic information, e.g. foreign genes, for many applications, including immunogenic or pharmaceutical compositions for pathogens other than mumps, gene therapy, and cell targeting
11/01/2007US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
11/01/2007US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007US20070253929 Derivatives of growth hormone and related proteins, and methods of use thereof
11/01/2007US20070253899 Dual Function Polymer Micelles
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2649514A1 Licorice polyphenol preparation
11/01/2007CA2645832A1 Hcv vaccinations
10/2007
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849865A1 RNAi MEDICINE HAVING NO ADVERSE EFFECTS
10/31/2007EP1849860A2 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP1849796A1 Anti-penicillin resistant pneumococci agent and novel 16-membered ring macrolide derivative
10/31/2007EP1849474A1 Antimicrobial peptide and use thereof
10/31/2007EP1849473A1 Chinese traditional medicine composition for treatment of avian influenza, method for preparation, and application thereof
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848741A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
10/31/2007EP1848723A1 New isothiazoloquinolones and related compounds as anti-infective agents
10/31/2007EP1848712A1 Atm inhibitors
10/31/2007EP1848703A2 Compounds and methods for modulating communication and virulence in quorum sensing bacteria
10/31/2007EP1848697A2 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
10/31/2007EP1848684A1 Ester-linked gemini surfactant compounds for use in gene therapy
10/31/2007EP1848457A2 Vaccines against neisseria meningitidis
10/31/2007EP1848448A1 Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse
10/31/2007EP1848418A2 Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
10/31/2007EP1848413A1 Parenteral combination therapy for infective conditions with drug resistant bacterium
10/31/2007EP1848401A1 Silver-ionized plant extraction liquid and use thereof
10/31/2007EP1848273A1 18-membered macrocycles and analogs thereof
10/31/2007EP1534678B1 Pleuromutilin derivatives as antimicrobbials
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1286998B2 Oxazolidinone derivatives with antibiotic activity
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1214054B1 Intranasal influenza virus vaccine
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007DE60125750T2 Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir A pharmaceutical formulation comprising carrier beads made with an applied layer valaciclovir
10/31/2007DE102006019619A1 Kristalline Modifikation von Cefuroximaxetil Crystalline modification of cefuroxime axetil
10/31/2007CN101065385A Rifamycin derivatives for treating microbial infections
10/31/2007CN101065150A 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
10/31/2007CN101065147A Naturally occurring IgM antibodies that bind lymphocytes
10/31/2007CN101065140A Use of histones for the early diagnosis and/or preventative therapy of virally-infected living cells and a biochip for carrying out said diagnosis
10/31/2007CN101065131A Antimicrobial agents
10/31/2007CN101065121A Therapeutic or preventive composition for gastric mucosa disease
1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 1798